Literature DB >> 11725740

Serum tryptase analysis in a woman with amniotic fluid embolism. A case report.

S C Farrar1, R B Gherman.   

Abstract

BACKGROUND: Recent studies have noted a striking similarity between amniotic fluid embolism (AFE) and anaphylaxis. Serum tryptase levels may therefore serve as a marker of mast cell degranulation in AFE cases. CASE: A 40-year-old woman, gravida 6, para 4, experienced the acute onset of facial erythema, eclampsia-type seizures, severe hypoxia, cardiac arrest and disseminated intravascular coagulation while in early active labor. The patient was declared dead 37 minutes after the onset of resuscitative efforts. At autopsy, fetal squames were found within the pulmonary tree, uterine blood vessels and brain. A peripheral venous blood specimen, obtained approximately one and a half hours postmortem, revealed a tryptase level of 4.7 ng/mL (normal, < 1).
CONCLUSION: An elevated serum tryptase level, in conjunction with our patient's clinical history, adds further supporting evidence to the concept of AFE as an anaphylactoid syndrome of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725740

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  10 in total

1.  Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism.

Authors:  Vittorio Fineschi; Irene Riezzo; Santina Cantatore; Cristoforo Pomara; Emanuela Turillazzi; Margherita Neri
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

2.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

3.  Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?

Authors:  Roberto Romero; Nicholas Kadar; Edi Vaisbuch; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-03-15       Impact factor: 3.886

4.  Amniotic fluid embolism with involvement of the brain, lungs, adrenal glands, and heart.

Authors:  J Balazic; T Rott; T Jancigaj; M Popović; M Zajfert-Slabe; V Svigelj
Journal:  Int J Legal Med       Date:  2003-05-06       Impact factor: 2.686

Review 5.  Amniotic fluid embolism: an evidence-based review.

Authors:  Agustín Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2009-11       Impact factor: 8.661

Review 6.  Amniotic fluid embolism: the known and not known.

Authors:  Michael D Benson
Journal:  Obstet Med       Date:  2013-11-29

Review 7.  Current concepts of immunology and diagnosis in amniotic fluid embolism.

Authors:  Michael D Benson
Journal:  Clin Dev Immunol       Date:  2011-09-29

Review 8.  Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.

Authors:  Francesco Paolo Busardò; Paola Frati; Simona Zaami; Vittorio Fineschi
Journal:  Int J Mol Sci       Date:  2015-03-23       Impact factor: 5.923

9.  Disseminated Intravascular Coagulation, Hemoperitoneum, and Reversible Ischemic Neurological Deficit Complicating Anaphylaxis to Prophylactic Antibiotics during Cesarean Delivery: A Case Report and Review of Literature.

Authors:  Mostafa A Borahay; Hassan M Harirah; Gayle Olson; Gokhan S Kilic; Sinem Karipcin; Gary D V Hankins
Journal:  AJP Rep       Date:  2011-01-24

10.  Two Obese Patients with Presumptive Diagnosis of Anaphylactoid Syndrome of Pregnancy Presenting at a Community Hospital.

Authors:  Brian K Kradel; Scarlett B Hinson; Carr J Smith
Journal:  Am J Case Rep       Date:  2016-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.